Authors:
LAPATTOREINILUOTO O
KIVISTO KT
POHJOLASINTONEN S
LUOMANMAKI K
NEUVONEN PJ
Citation: O. Lapattoreiniluoto et al., A PROSPECTIVE-STUDY OF ACUTE POISONINGS IN FINNISH HOSPITAL PATIENTS, Human & experimental toxicology, 17(6), 1998, pp. 307-311
Citation: Kt. Kivisto et al., DIFFERENT EFFECTS OF ITRACONAZOLE ON THE PHARMACOKINETICS OF FLUVASTATIN AND LOVASTATIN, British journal of clinical pharmacology, 46(1), 1998, pp. 49-53
Citation: Ts. Lamberg et al., CONCENTRATIONS AND EFFECTS OF BUSPIRONE ARE CONSIDERABLY REDUCED BY RIFAMPICIN, British journal of clinical pharmacology, 45(4), 1998, pp. 381-385
Citation: H. Luurila et al., EFFECT OF ITRACONAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM, European Journal of Clinical Pharmacology, 54(2), 1998, pp. 163-166
Authors:
BACKMAN JT
KIVISTO KT
OLKKOLA KT
NEUVONEN PJ
Citation: Jt. Backman et al., THE AREA UNDER THE PLASMA CONCENTRATION-TIME CURVE FOR ORAL MIDAZOLAMIS 400-FOLD LARGER DURING TREATMENT WITH ITRACONAZOLE THAN WITH RIFAMPICIN, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 53-58
Authors:
VARIS T
KAUKONEN KM
KIVISTO KT
NEUVONEN PJ
Citation: T. Varis et al., PLASMA METHYLPREDNISOLONE CONCENTRATIONS ARE CONSIDERABLY INCREASED BY ITRACONAZOLE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 472-472
Authors:
VILLIKKA K
KIVISTO KT
NYMAN L
ANTTILA M
NEUVONEN PJ
Citation: K. Villikka et al., RIFAMPICIN GREATLY REDUCES PLASMA-CONCENTRATIONS OF TAMOXIFEN, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 474-474
Citation: Jj. Lilja et al., GRAPEFRUIT JUICE-SIMVASTATIN INTERACTION - EFFECT ON SERUM CONCENTRATIONS OF SIMVASTATIN, SIMVASTATIN ACID, AND HMG-COA REDUCTASE INHIBITORS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 477-483
Authors:
VARIS T
KAUKONEN KM
KIVISTO KT
NEUVONEN PJ
Citation: T. Varis et al., PLASMA-CONCENTRATIONS AND EFFECTS OF ORAL METHYLPREDNISOLONE ARE CONSIDERABLY INCREASED BY ITRACONAZOLE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 363-368
Citation: T. Kantola et al., ERYTHROMYCIN AND VERAPAMIL CONSIDERABLY INCREASE SERUM SIMVASTATIN AND SIMVASTATIN ACID CONCENTRATIONS, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 177-182
Citation: T. Kantola et al., EFFECT OF ITRACONAZOLE ON THE PHARMACOKINETICS OF ATORVASTATIN, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 58-65
Citation: Ts. Lamberg et al., EFFECTS OF VERAPAMIL AND DILTIAZEM ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF BUSPIRONE, Clinical pharmacology and therapeutics, 63(6), 1998, pp. 640-645
Citation: T. Kantola et al., GRAPEFRUIT JUICE GREATLY INCREASES SERUM CONCENTRATIONS OF LOVASTATINAND LOVASTATIN ACID, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 397-402
Citation: Pj. Neuvonen et al., SIMVASTATIN BUT NOT PRAVASTATIN IS VERY SUSCEPTIBLE TO INTERACTION WITH THE CYP3A4 INHIBITOR ITRACONAZOLE, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 332-341
Citation: Pj. Neuvonen et al., GRAPEFRUIT JUICE GREATLY INCREASES SERUM LOVASTATIN AND LOVASTATIN ACID, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 94-94
Citation: Kt. Kivisto et al., VERAPAMIL AND DILTIAZEM INCREASE PLASMA BUSPIRONE CONCENTRATIONS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 96-96
Authors:
KIVISTO KT
GRIESE KU
STUVEN T
FRITZ P
FRIEDEL G
KROEMER HK
ZANGER UM
Citation: Kt. Kivisto et al., ANALYSIS OF CYP2D6 EXPRESSION IN HUMAN LUNG - IMPLICATIONS FOR THE ASSOCIATION BETWEEN CYP2D6 ACTIVITY AND SUSCEPTIBILITY TO LUNG-CANCER, Pharmacogenetics, 7(4), 1997, pp. 295-302
Citation: O. Lapatto et al., THE EFFECTS OF GLYCERYL TRINITRATE AND NICOTINIC-ACID OINTMENTS DURING COLD-EXPOSURE, Pharmacology & toxicology, 81(5), 1997, pp. 238-241
Citation: K. Laine et al., EFFECT OF DELAYED ADMINISTRATION OF ACTIVATED-CHARCOAL ON THE ABSORPTION OF CONVENTIONAL AND SLOW-RELEASE VERAPAMIL, Journal of toxicology. Clinical toxicology, 35(3), 1997, pp. 263-268
Authors:
VILLIKKA K
KIVISTO KT
LAMBERG TS
KANTOLA T
NEUVONEN PJ
Citation: K. Villikka et al., CONCENTRATIONS AND EFFECTS OF ZOPICLONE ARE GREATLY REDUCED BY RIFAMPICIN, British journal of clinical pharmacology, 43(5), 1997, pp. 471-474
Citation: K. Laine et al., PREVENTION OF AMLODIPINE ABSORPTION BY ACTIVATED-CHARCOAL - EFFECT OFDELAY IN CHARCOAL ADMINISTRATION, British journal of clinical pharmacology, 43(1), 1997, pp. 29-33
Authors:
LAINE K
KIVISTO KT
OJALAKARLSSON P
NEUVONEN PJ
Citation: K. Laine et al., EFFECT OF ACTIVATED-CHARCOAL ON THE PHARMACOKINETICS OF PHOLCODINE, WITH SPECIAL REFERENCE TO DELAYED CHARCOAL INGESTION, Therapeutic drug monitoring, 19(1), 1997, pp. 46-50